139 related articles for article (PubMed ID: 10384241)
21. Characterization of a naphthalene derivative inhibitor of retroviral integrases.
Daniel R; Myers CB; Kulkosky J; Taganov K; Greger JG; Merkel G; Weber IT; Harrison RW; Skalka AM
AIDS Res Hum Retroviruses; 2004 Feb; 20(2):135-44. PubMed ID: 15018700
[TBL] [Abstract][Full Text] [Related]
22. HIV-1 integrase: the next target for AIDS therapy?
d'Angelo J; Mouscadet JF; Desmaële D; Zouhiri F; Leh H
Pathol Biol (Paris); 2001 Apr; 49(3):237-46. PubMed ID: 11367559
[TBL] [Abstract][Full Text] [Related]
23. Identification of amino acids in HIV-1 and avian sarcoma virus integrase subsites required for specific recognition of the long terminal repeat Ends.
Chen A; Weber IT; Harrison RW; Leis J
J Biol Chem; 2006 Feb; 281(7):4173-82. PubMed ID: 16298997
[TBL] [Abstract][Full Text] [Related]
24. Divalent cations stimulate preferential recognition of a viral DNA end by HIV-1 integrase.
Yi J; Asante-Appiah E; Skalka AM
Biochemistry; 1999 Jun; 38(26):8458-68. PubMed ID: 10387092
[TBL] [Abstract][Full Text] [Related]
25. A crystal structure of the catalytic core domain of an avian sarcoma and leukemia virus integrase suggests an alternate dimeric assembly.
Ballandras A; Moreau K; Robert X; Confort MP; Merceron R; Haser R; Ronfort C; Gouet P
PLoS One; 2011; 6(8):e23032. PubMed ID: 21857987
[TBL] [Abstract][Full Text] [Related]
26. Three new structures of the core domain of HIV-1 integrase: an active site that binds magnesium.
Goldgur Y; Dyda F; Hickman AB; Jenkins TM; Craigie R; Davies DR
Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9150-4. PubMed ID: 9689049
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the functional domains of human foamy virus integrase using chimeric integrases.
Lee HS; Kang SY; Shin CG
Mol Cells; 2005 Apr; 19(2):246-55. PubMed ID: 15879710
[TBL] [Abstract][Full Text] [Related]
28. Identification of a small-molecule binding site at the dimer interface of the HIV integrase catalytic domain.
Molteni V; Greenwald J; Rhodes D; Hwang Y; Kwiatkowski W; Bushman FD; Siegel JS; Choe S
Acta Crystallogr D Biol Crystallogr; 2001 Apr; 57(Pt 4):536-44. PubMed ID: 11264582
[TBL] [Abstract][Full Text] [Related]
29. A metal-induced conformational change and activation of HIV-1 integrase.
Asante-Appiah E; Skalka AM
J Biol Chem; 1997 Jun; 272(26):16196-205. PubMed ID: 9195919
[TBL] [Abstract][Full Text] [Related]
30. Nucleophile selection for the endonuclease activities of human, ovine, and avian retroviral integrases.
Skinner LM; Sudol M; Harper AL; Katzman M
J Biol Chem; 2001 Jan; 276(1):114-24. PubMed ID: 11024025
[TBL] [Abstract][Full Text] [Related]
31. High-resolution structure of the catalytic domain of avian sarcoma virus integrase.
Bujacz G; Jaskólski M; Alexandratos J; Wlodawer A; Merkel G; Katz RA; Skalka AM
J Mol Biol; 1995 Oct; 253(2):333-46. PubMed ID: 7563093
[TBL] [Abstract][Full Text] [Related]
32. An amino acid in the central catalytic domain of three retroviral integrases that affects target site selection in nonviral DNA.
Harper AL; Sudol M; Katzman M
J Virol; 2003 Mar; 77(6):3838-45. PubMed ID: 12610159
[TBL] [Abstract][Full Text] [Related]
33. Atomic resolution structures of the core domain of avian sarcoma virus integrase and its D64N mutant.
Lubkowski J; Dauter Z; Yang F; Alexandratos J; Merkel G; Skalka AM; Wlodawer A
Biochemistry; 1999 Oct; 38(41):13512-22. PubMed ID: 10521258
[TBL] [Abstract][Full Text] [Related]
34. Structural determinants of metal-induced conformational changes in HIV-1 integrase.
Asante-Appiah E; Seeholzer SH; Skalka AM
J Biol Chem; 1998 Dec; 273(52):35078-87. PubMed ID: 9857042
[TBL] [Abstract][Full Text] [Related]
35. Constructing HIV-1 integrase tetramer and exploring influences of metal ions on forming integrase-DNA complex.
Wang LD; Liu CL; Chen WZ; Wang CX
Biochem Biophys Res Commun; 2005 Nov; 337(1):313-9. PubMed ID: 16188234
[TBL] [Abstract][Full Text] [Related]
36. Subcellular localization of avian sarcoma virus and human immunodeficiency virus type 1 integrases.
Kukolj G; Jones KS; Skalka AM
J Virol; 1997 Jan; 71(1):843-7. PubMed ID: 8985428
[TBL] [Abstract][Full Text] [Related]
37. Structural basis of Mos1 transposase inhibition by the anti-retroviral drug Raltegravir.
Wolkowicz UM; Morris ER; Robson M; Trubitsyna M; Richardson JM
ACS Chem Biol; 2014 Mar; 9(3):743-51. PubMed ID: 24397848
[TBL] [Abstract][Full Text] [Related]
38. Structure and function of HIV-1 integrase.
Chiu TK; Davies DR
Curr Top Med Chem; 2004; 4(9):965-77. PubMed ID: 15134551
[TBL] [Abstract][Full Text] [Related]
39. HIV-1 integrase: structural organization, conformational changes, and catalysis.
Asante-Appiah E; Skalka AM
Adv Virus Res; 1999; 52():351-69. PubMed ID: 10384242
[TBL] [Abstract][Full Text] [Related]
40. Computer aided study of ligand binding with catalytic domain of Avian sarcoma virus integrase and its ligand binding loops.
Kumar A; Shankar S; Kothekar V
J Biomol Struct Dyn; 2001 Dec; 19(3):449-58. PubMed ID: 11790143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
